Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation THT 2026

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Presenter: Ryan J. Tedford

March 03, 2026

Presentation THT 2026

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Presenter: Yogesh Reddy

March 02, 2026

Presentation THT 2026

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Presenter: Ryan J. Tedford

March 02, 2026

Presentation THT 2025

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Presenter: Marat Fudim

February 13, 2025

Presentation THT 2025

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Presenter: Jozef Bartunek

February 12, 2025

Presentation THT 2025

Remote Monitoring in PH: Where We Are and Where We Need to Go

Presenter: Sophia Airhart

February 12, 2025

Presentation THT 2025

Device Therapies in RV Failure: Escalation and De-Escalation

Presenter: Anthony Carnicelli

February 12, 2025

Presentation THT 2025

Sotatercept in Contemporary PAH Treatment Algorithm

Presenter: Thomas Cascino

February 12, 2025

Presentation THT 2025

Valvular Interventions in a Patient With Severe PH

Presenter: Estefania Oliveros

February 12, 2025

Presentation THT 2025

Are We a Step Closer to 'Curing' PH?: Top 5 Lessons Learnt From the 7th World Symposia

Presenter: Raymond Benza

February 12, 2025

Presentation THT 2025

Pulmonary Artery Denervation for PH: Ready for Primetime?

Presenter: Greg Lewis

February 12, 2025

Presentation THT 2025

PA Counter-Pulsation

Presenter: Jane Leopold

February 12, 2025

Presentation THT 2024

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Presenter: Ioana Preston

March 06, 2024

Presentation THT 2024

Counter Pulsation of the PA: Aria CV

Presenter: Jane A. Leopold

March 06, 2024

Presentation THT 2024

PADN for PH in Left Heart Disease

Presenter: Greg Lewis

March 06, 2024

Presentation THT 2024

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

Pulmonary Artery Denervation

Presenter: Alex M. K. Rothman

March 06, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

Presentation THT 2024

Disaggregating Left Heart Disease-Pulmonary Hypertension

Presenter: Bradley A. Maron

March 06, 2024

Advertisement

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Remote Monitoring in PH: Where We Are and Where We Need to Go

Device Therapies in RV Failure: Escalation and De-Escalation

Sotatercept in Contemporary PAH Treatment Algorithm

Valvular Interventions in a Patient With Severe PH

Are We a Step Closer to 'Curing' PH?: Top 5 Lessons Learnt From the 7th World Symposia

Pulmonary Artery Denervation for PH: Ready for Primetime?

PA Counter-Pulsation

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Counter Pulsation of the PA: Aria CV

PADN for PH in Left Heart Disease

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Pulmonary Artery Denervation

PH-HFpEF: Levosimendan

Disaggregating Left Heart Disease-Pulmonary Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content